Coverage varies by region, plan, and whether you meet certain criteria
Who Is Well-Suited Patients in the early-to-mid phase of GLP-1 treatment represent the strongest candidates for a concurrent photobiomodulation protocol specifically those who want to proactively support their skins collagen biology and lean mass during the loss process, and those with mild-to-moderate laxity (skin that feels loose or less firm but does not involve significant excess skin surface area)
From 2030 to 2035, the market is forecast to grow from USD 39,528 million to USD 65,364 million, adding another USD 25836.0 million, which constitutes 45.2% of the overall ten-year expansion
Regardless of which med youre assigned, all GLP-1s work best when paired with sustainable lifestyle changes (like balanced eating and consistent physical activity)
When used for weight loss, they enhance your bodys own signals of fullness
This approach would typically involve close monitoring by a healthcare provider to ensure that the lower doses are still effective in managing blood sugar and that the patient remains safe from potential side effects